For Jani Viox, clinical research is more than a profession—it’s personal. As a senior coordinator of client services at Advarra, Jani works closely with research sites and sponsors to support institutional review board (IRB) submissions with clarity, responsiveness, and care. Her perspective is shaped by more than two decades on the site side, as well as by family experiences that reinforce why ethical, compassionate research matters.
In this Q&A, Jani shares what drew her to Advarra, how her background informs the way she supports customers, and what she’s looking forward to as Advarra continues to evolve through service, collaboration, and ongoing investment in technology.
How did your personal and professional experiences shape your connection to clinical research?
My connection to research is really twofold. Professionally, I spent more than 20 years at a research site as a regulatory specialist, working with IRBs every day. I saw firsthand how much time, care, and collaboration it takes to run studies ethically and effectively, and that gave me a deep respect for the oversight process.
Personally, I also have an extensive family history of cancer. I’ve watched family members, including my nephew, benefit directly from research advances, including participation in early-stage studies. Seeing how research can make a meaningful difference in people’s lives reinforced for me how important it is to do this work the right way—with ethics, compassion, and participant safety always at the center.
What motivated you to join Advarra, and how did you see it addressing real research challenges?
Coming from the site side, I worked with many IRBs, and I know how important it is to be able to connect with someone who understands your study. In my early interactions with Advarra, that accessibility and willingness to engage stood out to me.
There can be a lot of misunderstanding around research, especially from a patient perspective. Some people worry they won’t be fully informed or protected. Advarra plays an important role in reinforcing informed consent, transparency, and ethical oversight, helping ensure participants understand what they’re agreeing to and why safeguards are in place.
I joined Advarra during COVID, which was an especially challenging time for research. Seeing how a national IRB could coordinate quickly and thoughtfully, while keeping safety and ethics at the forefront, gave me a strong sense of pride in being part of that work.
How does Advarra support customers when timing and stakes are high?
One experience that has stayed with me involved a child traveling from another country who urgently needed access to treatment. The situation required close coordination and timely review. Our team worked with the board to move as efficiently as possible while maintaining appropriate oversight.
Having been on the other side of similar situations, I understand how much each day can matter for families. We approach this work with that awareness by being responsive, answering the phone, and working together across teams to support sites and sponsors through complex, time-sensitive moments.
What excites you most about the next generation of CIRBI, Advarra’s eIRB platform?
I’m excited about how the platform continues to evolve based on client feedback. Even today, the system reflects a strong focus on usability and transparency, and the next generation builds on that foundation.
The goal is to make it easier for clients to navigate submissions, understand study status, and access their information in one place. Features like clearer study histories and more accessible reporting are designed to support efficiency and visibility throughout the process. It’s encouraging to see the technology continue to align with the way our teams work, combining thoughtful innovation with a focus on trust and collaboration.
Want to learn more? Check out this overview of Advarra’s review services or contact us to ask an expert a specific question.
